Edwards Lifesciences Corporation (EW) Acquires BMEYE for $42 Million
10/10/2012 7:27:31 AM
More...
|
BMEYE Launches a Noninvasive, Breakthrough Parameter for Delivery of Oxygen (DO2I) and new Fluid Management Parameters at the European Society of Anesthesia Congress
6/14/2011 9:03:23 AM
More...
|
BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States
11/18/2010 7:35:03 AM
More...
|
BMEYE Completes EUR 6 Million Series B Financing Round New Investors Earlybird and 360 Capital Partners led the Round
10/8/2009 7:11:04 AM
More...
|
BMEYE Announces FDA 510(K) Clearance for Nexfin(TM)
12/10/2007 10:40:20 AM
More...
|
BMEYE Announces CE Mark Approval of Nexfin(TM)
7/23/2007 8:46:30 AM
More...
|